nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—CYP3A4—Ticagrelor—coronary artery disease	0.0675	0.146	CbGbCtD
Dantrolene—CYP3A4—Fenofibrate—coronary artery disease	0.0602	0.131	CbGbCtD
Dantrolene—CYP3A4—Gemfibrozil—coronary artery disease	0.0481	0.104	CbGbCtD
Dantrolene—CYP3A4—Clopidogrel—coronary artery disease	0.0417	0.0905	CbGbCtD
Dantrolene—CYP3A4—Eplerenone—coronary artery disease	0.0388	0.0841	CbGbCtD
Dantrolene—CYP3A4—Enalapril—coronary artery disease	0.0346	0.075	CbGbCtD
Dantrolene—CYP3A4—Ezetimibe—coronary artery disease	0.0269	0.0583	CbGbCtD
Dantrolene—CYP3A4—Rosuvastatin—coronary artery disease	0.0269	0.0583	CbGbCtD
Dantrolene—CYP3A4—Simvastatin—coronary artery disease	0.025	0.0542	CbGbCtD
Dantrolene—CYP3A4—Lovastatin—coronary artery disease	0.0245	0.053	CbGbCtD
Dantrolene—CYP3A4—Pravastatin—coronary artery disease	0.0245	0.053	CbGbCtD
Dantrolene—CYP3A4—Atorvastatin—coronary artery disease	0.0223	0.0483	CbGbCtD
Dantrolene—CYP3A4—Losartan—coronary artery disease	0.0204	0.0442	CbGbCtD
Dantrolene—RYR3—heart—coronary artery disease	0.00371	0.212	CbGeAlD
Dantrolene—RYR3—cardiovascular system—coronary artery disease	0.0035	0.2	CbGeAlD
Dantrolene—RYR3—blood—coronary artery disease	0.00277	0.158	CbGeAlD
Dantrolene—RYR1—heart—coronary artery disease	0.00266	0.152	CbGeAlD
Dantrolene—RYR1—cardiovascular system—coronary artery disease	0.00251	0.144	CbGeAlD
Dantrolene—RYR1—blood—coronary artery disease	0.00198	0.114	CbGeAlD
Dantrolene—RYR3—Alzheimers Disease—APOE—coronary artery disease	0.00106	0.00583	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—FXYD1—coronary artery disease	0.00105	0.00575	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—ADM—coronary artery disease	0.00103	0.00564	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—PDE4B—coronary artery disease	0.001	0.0055	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—CFTR—coronary artery disease	0.000934	0.00513	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	0.000934	0.00513	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—ATP2A2—coronary artery disease	0.000921	0.00506	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—GSK3B—coronary artery disease	0.000919	0.00505	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—GJA1—coronary artery disease	0.000895	0.00492	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—IGFBP3—coronary artery disease	0.000892	0.0049	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—ATP2A2—coronary artery disease	0.000892	0.0049	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	0.000891	0.00489	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—ACTB—coronary artery disease	0.000881	0.00484	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—ADRB2—coronary artery disease	0.000879	0.00483	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—PRKCE—coronary artery disease	0.000868	0.00477	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—GJA1—coronary artery disease	0.000868	0.00476	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—CAMK2D—coronary artery disease	0.000864	0.00475	CbGpPWpGaD
Dantrolene—RYR1—Ion channel transport—ATP2A2—coronary artery disease	0.000861	0.00473	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—PRKCE—coronary artery disease	0.000841	0.00462	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—CAMK2D—coronary artery disease	0.000837	0.0046	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—ADRB1—coronary artery disease	0.0008	0.00439	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—CALR—coronary artery disease	0.000796	0.00437	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—FXYD1—coronary artery disease	0.000772	0.00424	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—RYR2—coronary artery disease	0.000747	0.0041	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—COX5B—coronary artery disease	0.000747	0.0041	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—PLN—coronary artery disease	0.000726	0.00399	CbGpPWpGaD
Dantrolene—CYP3A4—Liver X Receptor Pathway—ABCG5—coronary artery disease	0.000722	0.00396	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—PRKCD—coronary artery disease	0.000702	0.00386	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—CFTR—coronary artery disease	0.000688	0.00378	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ATP1A1—coronary artery disease	0.000688	0.00378	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—PRKCD—coronary artery disease	0.00068	0.00374	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—IL1B—coronary artery disease	0.000676	0.00372	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—HK2—coronary artery disease	0.000675	0.00371	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—CASP3—coronary artery disease	0.000675	0.00371	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—GJA1—coronary artery disease	0.00066	0.00363	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC6A6—coronary artery disease	0.000657	0.00361	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—ADRB2—coronary artery disease	0.000648	0.00356	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ATP4A—coronary artery disease	0.000647	0.00356	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	0.000647	0.00356	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—PRKCE—coronary artery disease	0.00064	0.00351	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—GJA1—coronary artery disease	0.00064	0.00351	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—PRKCE—coronary artery disease	0.00062	0.0034	CbGpPWpGaD
Dantrolene—CYP3A4—Estrogen metabolism—SULT1E1—coronary artery disease	0.000602	0.00331	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	0.000574	0.00315	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	0.000574	0.00315	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—RYR2—coronary artery disease	0.00055	0.00302	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—COX5B—coronary artery disease	0.00055	0.00302	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—PLN—coronary artery disease	0.000535	0.00294	CbGpPWpGaD
Dantrolene—CYP3A4—Tamoxifen metabolism—SULT1E1—coronary artery disease	0.000533	0.00292	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—CREB1—coronary artery disease	0.000532	0.00292	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	0.00053	0.00291	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—HK1—coronary artery disease	0.00053	0.00291	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ABCG5—coronary artery disease	0.00053	0.00291	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—PRKCD—coronary artery disease	0.000518	0.00284	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—MAPK1—coronary artery disease	0.000516	0.00283	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—PRKCD—coronary artery disease	0.000502	0.00275	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—HK2—coronary artery disease	0.000498	0.00273	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—TNF—coronary artery disease	0.000491	0.0027	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC27A1—coronary artery disease	0.000477	0.00262	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ATP4A—coronary artery disease	0.000477	0.00262	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—NOS3—coronary artery disease	0.000464	0.00255	CbGpPWpGaD
Dantrolene—CYP3A4—Aflatoxin B1 metabolism—GSTM1—coronary artery disease	0.000458	0.00252	CbGpPWpGaD
Dantrolene—CYP3A4—Estrogen metabolism—SULT1A1—coronary artery disease	0.000451	0.00248	CbGpPWpGaD
Dantrolene—CYP3A4—Estrogen metabolism—GSTA1—coronary artery disease	0.000441	0.00242	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ATP2B1—coronary artery disease	0.000423	0.00232	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC22A3—coronary artery disease	0.000423	0.00232	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	0.000406	0.00223	CbGpPWpGaD
Dantrolene—CYP3A4—Tamoxifen metabolism—SULT1A1—coronary artery disease	0.000399	0.00219	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	0.000397	0.00218	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—IL1B—coronary artery disease	0.000395	0.00217	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—CETP—coronary artery disease	0.000392	0.00215	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—CREB1—coronary artery disease	0.000392	0.00215	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—HK1—coronary artery disease	0.000391	0.00215	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC8A1—coronary artery disease	0.000391	0.00215	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ABCG5—coronary artery disease	0.000391	0.00215	CbGpPWpGaD
Dantrolene—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—coronary artery disease	0.00039	0.00214	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—TFRC—coronary artery disease	0.000372	0.00204	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—PLAT—coronary artery disease	0.000346	0.0019	CbGpPWpGaD
Dantrolene—CYP3A4—blood—coronary artery disease	0.000345	0.0197	CbGeAlD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—NOS3—coronary artery disease	0.000342	0.00188	CbGpPWpGaD
Dantrolene—CYP3A4—Xenobiotics—CYP2C19—coronary artery disease	0.000318	0.00175	CbGpPWpGaD
Dantrolene—CYP3A4—Tamoxifen metabolism—CYP2C19—coronary artery disease	0.000306	0.00168	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ATP2A2—coronary artery disease	0.0003	0.00165	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—PLG—coronary artery disease	0.000294	0.00161	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC9A1—coronary artery disease	0.000292	0.00161	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—IL1B—coronary artery disease	0.000291	0.0016	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—CETP—coronary artery disease	0.000289	0.00159	CbGpPWpGaD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—SULT1A1—coronary artery disease	0.000285	0.00156	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—TFRC—coronary artery disease	0.000274	0.00151	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—HMOX1—coronary artery disease	0.000271	0.00149	CbGpPWpGaD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—coronary artery disease	0.000271	0.00149	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—APOB—coronary artery disease	0.00026	0.00143	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—PLAT—coronary artery disease	0.000255	0.0014	CbGpPWpGaD
Dantrolene—CYP3A4—Aflatoxin activation and detoxification—GGT1—coronary artery disease	0.00025	0.00137	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—IL6—coronary artery disease	0.000231	0.00127	CbGpPWpGaD
Dantrolene—CYP3A4—Tryptophan metabolism—HADH—coronary artery disease	0.000227	0.00125	CbGpPWpGaD
Dantrolene—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—coronary artery disease	0.000222	0.00122	CbGpPWpGaD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C19—coronary artery disease	0.000218	0.0012	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—PLG—coronary artery disease	0.000217	0.00119	CbGpPWpGaD
Dantrolene—CYP3A4—Estrogen metabolism—GSTM1—coronary artery disease	0.000215	0.00118	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—APOA1—coronary artery disease	0.000206	0.00113	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—HMOX1—coronary artery disease	0.0002	0.0011	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—APOB—coronary artery disease	0.000192	0.00105	CbGpPWpGaD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11B2—coronary artery disease	0.000189	0.00104	CbGpPWpGaD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP11B2—coronary artery disease	0.000187	0.00103	CbGpPWpGaD
Dantrolene—Dermatitis—Clopidogrel—coronary artery disease	0.000185	0.000545	CcSEcCtD
Dantrolene—Asthenia—Valsartan—coronary artery disease	0.000185	0.000545	CcSEcCtD
Dantrolene—Hypertension—Timolol—coronary artery disease	0.000185	0.000545	CcSEcCtD
Dantrolene—Pain—Furosemide—coronary artery disease	0.000185	0.000544	CcSEcCtD
Dantrolene—Constipation—Furosemide—coronary artery disease	0.000185	0.000544	CcSEcCtD
Dantrolene—Hypersensitivity—Niacin—coronary artery disease	0.000185	0.000544	CcSEcCtD
Dantrolene—Ill-defined disorder—Lisinopril—coronary artery disease	0.000184	0.000543	CcSEcCtD
Dantrolene—Discomfort—Ramipril—coronary artery disease	0.000184	0.000543	CcSEcCtD
Dantrolene—Asthenia—Olmesartan—coronary artery disease	0.000184	0.000542	CcSEcCtD
Dantrolene—Headache—Clopidogrel—coronary artery disease	0.000184	0.000542	CcSEcCtD
Dantrolene—Rash—Lovastatin—coronary artery disease	0.000184	0.000542	CcSEcCtD
Dantrolene—Dermatitis—Lovastatin—coronary artery disease	0.000184	0.000542	CcSEcCtD
Dantrolene—Anaemia—Lisinopril—coronary artery disease	0.000183	0.000541	CcSEcCtD
Dantrolene—Dyspepsia—Losartan—coronary artery disease	0.000183	0.000541	CcSEcCtD
Dantrolene—Feeling abnormal—Perindopril—coronary artery disease	0.000183	0.00054	CcSEcCtD
Dantrolene—Headache—Lovastatin—coronary artery disease	0.000183	0.000539	CcSEcCtD
Dantrolene—Pruritus—Valsartan—coronary artery disease	0.000182	0.000537	CcSEcCtD
Dantrolene—Dry mouth—Ramipril—coronary artery disease	0.000182	0.000537	CcSEcCtD
Dantrolene—Myalgia—Timolol—coronary artery disease	0.000182	0.000537	CcSEcCtD
Dantrolene—Vomiting—Ezetimibe—coronary artery disease	0.000182	0.000536	CcSEcCtD
Dantrolene—Hypersensitivity—Pravastatin—coronary artery disease	0.000182	0.000536	CcSEcCtD
Dantrolene—Gastrointestinal pain—Perindopril—coronary artery disease	0.000182	0.000536	CcSEcCtD
Dantrolene—Pruritus—Olmesartan—coronary artery disease	0.000181	0.000535	CcSEcCtD
Dantrolene—Decreased appetite—Losartan—coronary artery disease	0.000181	0.000534	CcSEcCtD
Dantrolene—Abdominal pain—Captopril—coronary artery disease	0.000181	0.000533	CcSEcCtD
Dantrolene—Body temperature increased—Captopril—coronary artery disease	0.000181	0.000533	CcSEcCtD
Dantrolene—Dizziness—Simvastatin—coronary artery disease	0.00018	0.000532	CcSEcCtD
Dantrolene—Rash—Ezetimibe—coronary artery disease	0.00018	0.000532	CcSEcCtD
Dantrolene—Dermatitis—Ezetimibe—coronary artery disease	0.00018	0.000531	CcSEcCtD
Dantrolene—Confusional state—Ramipril—coronary artery disease	0.00018	0.000531	CcSEcCtD
Dantrolene—Discomfort—Timolol—coronary artery disease	0.00018	0.000531	CcSEcCtD
Dantrolene—Asthenia—Niacin—coronary artery disease	0.00018	0.00053	CcSEcCtD
Dantrolene—Fatigue—Losartan—coronary artery disease	0.00018	0.00053	CcSEcCtD
Dantrolene—Headache—Ezetimibe—coronary artery disease	0.000179	0.000528	CcSEcCtD
Dantrolene—Malaise—Lisinopril—coronary artery disease	0.000179	0.000528	CcSEcCtD
Dantrolene—Anaphylactic shock—Ramipril—coronary artery disease	0.000179	0.000527	CcSEcCtD
Dantrolene—Dry mouth—Timolol—coronary artery disease	0.000178	0.000525	CcSEcCtD
Dantrolene—Constipation—Losartan—coronary artery disease	0.000178	0.000525	CcSEcCtD
Dantrolene—Pain—Losartan—coronary artery disease	0.000178	0.000525	CcSEcCtD
Dantrolene—Vomiting—Eplerenone—coronary artery disease	0.000178	0.000525	CcSEcCtD
Dantrolene—Feeling abnormal—Furosemide—coronary artery disease	0.000178	0.000525	CcSEcCtD
Dantrolene—Leukopenia—Lisinopril—coronary artery disease	0.000178	0.000524	CcSEcCtD
Dantrolene—Nausea—Fenofibrate—coronary artery disease	0.000177	0.000523	CcSEcCtD
Dantrolene—Pruritus—Niacin—coronary artery disease	0.000177	0.000522	CcSEcCtD
Dantrolene—Asthenia—Pravastatin—coronary artery disease	0.000177	0.000522	CcSEcCtD
Dantrolene—Gastrointestinal pain—Furosemide—coronary artery disease	0.000177	0.000521	CcSEcCtD
Dantrolene—Rash—Eplerenone—coronary artery disease	0.000176	0.00052	CcSEcCtD
Dantrolene—Urticaria—Perindopril—coronary artery disease	0.000176	0.00052	CcSEcCtD
Dantrolene—Hypersensitivity—Trandolapril—coronary artery disease	0.000176	0.00052	CcSEcCtD
Dantrolene—Dermatitis—Eplerenone—coronary artery disease	0.000176	0.00052	CcSEcCtD
Dantrolene—Diarrhoea—Valsartan—coronary artery disease	0.000176	0.00052	CcSEcCtD
Dantrolene—Confusional state—Timolol—coronary artery disease	0.000176	0.000519	CcSEcCtD
Dantrolene—Hypersensitivity—Enalapril—coronary artery disease	0.000176	0.000518	CcSEcCtD
Dantrolene—Abdominal pain—Perindopril—coronary artery disease	0.000176	0.000518	CcSEcCtD
Dantrolene—Body temperature increased—Perindopril—coronary artery disease	0.000176	0.000518	CcSEcCtD
Dantrolene—Diarrhoea—Olmesartan—coronary artery disease	0.000175	0.000517	CcSEcCtD
Dantrolene—Headache—Eplerenone—coronary artery disease	0.000175	0.000517	CcSEcCtD
Dantrolene—Thrombocytopenia—Ramipril—coronary artery disease	0.000175	0.000516	CcSEcCtD
Dantrolene—Anaphylactic shock—Timolol—coronary artery disease	0.000175	0.000515	CcSEcCtD
Dantrolene—Pruritus—Pravastatin—coronary artery disease	0.000174	0.000514	CcSEcCtD
Dantrolene—Nausea—Clopidogrel—coronary artery disease	0.000174	0.000514	CcSEcCtD
Dantrolene—Tachycardia—Ramipril—coronary artery disease	0.000174	0.000514	CcSEcCtD
Dantrolene—Vomiting—Simvastatin—coronary artery disease	0.000173	0.000511	CcSEcCtD
Dantrolene—Hypersensitivity—Telmisartan—coronary artery disease	0.000173	0.000511	CcSEcCtD
Dantrolene—Nausea—Lovastatin—coronary artery disease	0.000173	0.000511	CcSEcCtD
Dantrolene—Hyperhidrosis—Ramipril—coronary artery disease	0.000173	0.000509	CcSEcCtD
Dantrolene—Rash—Simvastatin—coronary artery disease	0.000172	0.000507	CcSEcCtD
Dantrolene—Dermatitis—Simvastatin—coronary artery disease	0.000172	0.000507	CcSEcCtD
Dantrolene—Asthenia—Trandolapril—coronary artery disease	0.000172	0.000507	CcSEcCtD
Dantrolene—Feeling abnormal—Losartan—coronary artery disease	0.000172	0.000506	CcSEcCtD
Dantrolene—Urticaria—Furosemide—coronary artery disease	0.000172	0.000506	CcSEcCtD
Dantrolene—Diarrhoea—Niacin—coronary artery disease	0.000171	0.000505	CcSEcCtD
Dantrolene—Asthenia—Enalapril—coronary artery disease	0.000171	0.000505	CcSEcCtD
Dantrolene—Headache—Simvastatin—coronary artery disease	0.000171	0.000504	CcSEcCtD
Dantrolene—Body temperature increased—Furosemide—coronary artery disease	0.000171	0.000503	CcSEcCtD
Dantrolene—Abdominal pain—Furosemide—coronary artery disease	0.000171	0.000503	CcSEcCtD
Dantrolene—Gastrointestinal pain—Losartan—coronary artery disease	0.00017	0.000502	CcSEcCtD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—IL6—coronary artery disease	0.00017	0.000935	CbGpPWpGaD
Dantrolene—Dizziness—Valsartan—coronary artery disease	0.00017	0.000502	CcSEcCtD
Dantrolene—Anorexia—Ramipril—coronary artery disease	0.00017	0.000502	CcSEcCtD
Dantrolene—Nausea—Ezetimibe—coronary artery disease	0.00017	0.000501	CcSEcCtD
Dantrolene—Dizziness—Olmesartan—coronary artery disease	0.00017	0.0005	CcSEcCtD
Dantrolene—Pruritus—Trandolapril—coronary artery disease	0.000169	0.0005	CcSEcCtD
Dantrolene—Myalgia—Lisinopril—coronary artery disease	0.000169	0.000498	CcSEcCtD
Dantrolene—Hyperhidrosis—Timolol—coronary artery disease	0.000169	0.000498	CcSEcCtD
Dantrolene—Asthenia—Telmisartan—coronary artery disease	0.000169	0.000498	CcSEcCtD
Dantrolene—Pruritus—Enalapril—coronary artery disease	0.000169	0.000498	CcSEcCtD
Dantrolene—Diarrhoea—Pravastatin—coronary artery disease	0.000169	0.000497	CcSEcCtD
Dantrolene—CYP3A4—Tryptophan metabolism—ALDH2—coronary artery disease	0.000168	0.000921	CbGpPWpGaD
Dantrolene—Discomfort—Lisinopril—coronary artery disease	0.000167	0.000492	CcSEcCtD
Dantrolene—Anorexia—Timolol—coronary artery disease	0.000166	0.000491	CcSEcCtD
Dantrolene—Pruritus—Telmisartan—coronary artery disease	0.000166	0.000491	CcSEcCtD
Dantrolene—Nausea—Eplerenone—coronary artery disease	0.000166	0.00049	CcSEcCtD
Dantrolene—Dizziness—Niacin—coronary artery disease	0.000166	0.000488	CcSEcCtD
Dantrolene—Urticaria—Losartan—coronary artery disease	0.000165	0.000488	CcSEcCtD
Dantrolene—Dry mouth—Lisinopril—coronary artery disease	0.000165	0.000487	CcSEcCtD
Dantrolene—Abdominal pain—Losartan—coronary artery disease	0.000165	0.000486	CcSEcCtD
Dantrolene—Body temperature increased—Losartan—coronary artery disease	0.000165	0.000486	CcSEcCtD
Dantrolene—Asthenia—Captopril—coronary artery disease	0.000164	0.000484	CcSEcCtD
Dantrolene—Diarrhoea—Trandolapril—coronary artery disease	0.000164	0.000483	CcSEcCtD
Dantrolene—Vomiting—Valsartan—coronary artery disease	0.000164	0.000483	CcSEcCtD
Dantrolene—Confusional state—Lisinopril—coronary artery disease	0.000163	0.000482	CcSEcCtD
Dantrolene—Diarrhoea—Enalapril—coronary artery disease	0.000163	0.000481	CcSEcCtD
Dantrolene—Dizziness—Pravastatin—coronary artery disease	0.000163	0.000481	CcSEcCtD
Dantrolene—Vomiting—Olmesartan—coronary artery disease	0.000163	0.000481	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—ALB—coronary artery disease	0.000163	0.000894	CbGpPWpGaD
Dantrolene—Musculoskeletal discomfort—Ramipril—coronary artery disease	0.000163	0.00048	CcSEcCtD
Dantrolene—Rash—Valsartan—coronary artery disease	0.000162	0.000479	CcSEcCtD
Dantrolene—Dermatitis—Valsartan—coronary artery disease	0.000162	0.000478	CcSEcCtD
Dantrolene—Nausea—Simvastatin—coronary artery disease	0.000162	0.000478	CcSEcCtD
Dantrolene—Anaphylactic shock—Lisinopril—coronary artery disease	0.000162	0.000478	CcSEcCtD
Dantrolene—Pruritus—Captopril—coronary artery disease	0.000162	0.000477	CcSEcCtD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—coronary artery disease	0.000162	0.000889	CbGpPWpGaD
Dantrolene—Rash—Olmesartan—coronary artery disease	0.000162	0.000477	CcSEcCtD
Dantrolene—Insomnia—Ramipril—coronary artery disease	0.000162	0.000476	CcSEcCtD
Dantrolene—Dermatitis—Olmesartan—coronary artery disease	0.000161	0.000476	CcSEcCtD
Dantrolene—Headache—Valsartan—coronary artery disease	0.000161	0.000476	CcSEcCtD
Dantrolene—Diarrhoea—Telmisartan—coronary artery disease	0.000161	0.000475	CcSEcCtD
Dantrolene—Headache—Olmesartan—coronary artery disease	0.000161	0.000474	CcSEcCtD
Dantrolene—Asthenia—Perindopril—coronary artery disease	0.000159	0.00047	CcSEcCtD
Dantrolene—Vomiting—Niacin—coronary artery disease	0.000159	0.00047	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Timolol—coronary artery disease	0.000159	0.000469	CcSEcCtD
Dantrolene—Hypersensitivity—Furosemide—coronary artery disease	0.000159	0.000469	CcSEcCtD
Dantrolene—Somnolence—Ramipril—coronary artery disease	0.000159	0.000468	CcSEcCtD
Dantrolene—Thrombocytopenia—Lisinopril—coronary artery disease	0.000159	0.000468	CcSEcCtD
Dantrolene—Dizziness—Trandolapril—coronary artery disease	0.000158	0.000467	CcSEcCtD
Dantrolene—Tachycardia—Lisinopril—coronary artery disease	0.000158	0.000466	CcSEcCtD
Dantrolene—Insomnia—Timolol—coronary artery disease	0.000158	0.000466	CcSEcCtD
Dantrolene—Rash—Niacin—coronary artery disease	0.000158	0.000466	CcSEcCtD
Dantrolene—Dermatitis—Niacin—coronary artery disease	0.000158	0.000465	CcSEcCtD
Dantrolene—Dizziness—Enalapril—coronary artery disease	0.000158	0.000465	CcSEcCtD
Dantrolene—Dyspepsia—Ramipril—coronary artery disease	0.000157	0.000464	CcSEcCtD
Dantrolene—Pruritus—Perindopril—coronary artery disease	0.000157	0.000463	CcSEcCtD
Dantrolene—Headache—Niacin—coronary artery disease	0.000157	0.000463	CcSEcCtD
Dantrolene—Vomiting—Pravastatin—coronary artery disease	0.000157	0.000462	CcSEcCtD
Dantrolene—Hyperhidrosis—Lisinopril—coronary artery disease	0.000157	0.000462	CcSEcCtD
Dantrolene—Diarrhoea—Captopril—coronary artery disease	0.000157	0.000462	CcSEcCtD
Dantrolene—Dizziness—Telmisartan—coronary artery disease	0.000156	0.000459	CcSEcCtD
Dantrolene—Rash—Pravastatin—coronary artery disease	0.000155	0.000458	CcSEcCtD
Dantrolene—Dermatitis—Pravastatin—coronary artery disease	0.000155	0.000458	CcSEcCtD
Dantrolene—Decreased appetite—Ramipril—coronary artery disease	0.000155	0.000458	CcSEcCtD
Dantrolene—Somnolence—Timolol—coronary artery disease	0.000155	0.000458	CcSEcCtD
Dantrolene—Asthenia—Furosemide—coronary artery disease	0.000155	0.000457	CcSEcCtD
Dantrolene—Headache—Pravastatin—coronary artery disease	0.000154	0.000456	CcSEcCtD
Dantrolene—Anorexia—Lisinopril—coronary artery disease	0.000154	0.000455	CcSEcCtD
Dantrolene—Fatigue—Ramipril—coronary artery disease	0.000154	0.000454	CcSEcCtD
Dantrolene—Dyspepsia—Timolol—coronary artery disease	0.000154	0.000453	CcSEcCtD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP11B2—coronary artery disease	0.000154	0.000843	CbGpPWpGaD
Dantrolene—Hypersensitivity—Losartan—coronary artery disease	0.000153	0.000453	CcSEcCtD
Dantrolene—Nausea—Valsartan—coronary artery disease	0.000153	0.000451	CcSEcCtD
Dantrolene—Pruritus—Furosemide—coronary artery disease	0.000153	0.00045	CcSEcCtD
Dantrolene—Constipation—Ramipril—coronary artery disease	0.000153	0.00045	CcSEcCtD
Dantrolene—Nausea—Olmesartan—coronary artery disease	0.000152	0.000449	CcSEcCtD
Dantrolene—Vomiting—Trandolapril—coronary artery disease	0.000152	0.000449	CcSEcCtD
Dantrolene—Diarrhoea—Perindopril—coronary artery disease	0.000152	0.000448	CcSEcCtD
Dantrolene—Decreased appetite—Timolol—coronary artery disease	0.000152	0.000448	CcSEcCtD
Dantrolene—Vomiting—Enalapril—coronary artery disease	0.000152	0.000447	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—APOA1—coronary artery disease	0.000152	0.000832	CbGpPWpGaD
Dantrolene—Dizziness—Captopril—coronary artery disease	0.000151	0.000446	CcSEcCtD
Dantrolene—Rash—Trandolapril—coronary artery disease	0.000151	0.000445	CcSEcCtD
Dantrolene—Dermatitis—Trandolapril—coronary artery disease	0.000151	0.000445	CcSEcCtD
Dantrolene—Fatigue—Timolol—coronary artery disease	0.000151	0.000444	CcSEcCtD
Dantrolene—Rash—Enalapril—coronary artery disease	0.00015	0.000443	CcSEcCtD
Dantrolene—Dermatitis—Enalapril—coronary artery disease	0.00015	0.000443	CcSEcCtD
Dantrolene—Headache—Trandolapril—coronary artery disease	0.00015	0.000442	CcSEcCtD
Dantrolene—Vomiting—Telmisartan—coronary artery disease	0.00015	0.000441	CcSEcCtD
Dantrolene—Asthenia—Losartan—coronary artery disease	0.000149	0.000441	CcSEcCtD
Dantrolene—Headache—Enalapril—coronary artery disease	0.000149	0.000441	CcSEcCtD
Dantrolene—Pain—Timolol—coronary artery disease	0.000149	0.00044	CcSEcCtD
Dantrolene—Nausea—Niacin—coronary artery disease	0.000149	0.000439	CcSEcCtD
Dantrolene—Rash—Telmisartan—coronary artery disease	0.000148	0.000437	CcSEcCtD
Dantrolene—Dermatitis—Telmisartan—coronary artery disease	0.000148	0.000437	CcSEcCtD
Dantrolene—Diarrhoea—Furosemide—coronary artery disease	0.000148	0.000436	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Lisinopril—coronary artery disease	0.000148	0.000435	CcSEcCtD
Dantrolene—Pruritus—Losartan—coronary artery disease	0.000147	0.000435	CcSEcCtD
Dantrolene—Headache—Telmisartan—coronary artery disease	0.000147	0.000435	CcSEcCtD
Dantrolene—Feeling abnormal—Ramipril—coronary artery disease	0.000147	0.000434	CcSEcCtD
Dantrolene—Dizziness—Perindopril—coronary artery disease	0.000147	0.000433	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—SULT4A1—coronary artery disease	0.000147	0.000805	CbGpPWpGaD
Dantrolene—Insomnia—Lisinopril—coronary artery disease	0.000147	0.000432	CcSEcCtD
Dantrolene—Nausea—Pravastatin—coronary artery disease	0.000146	0.000432	CcSEcCtD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—coronary artery disease	0.000146	0.000804	CbGpPWpGaD
Dantrolene—Gastrointestinal pain—Ramipril—coronary artery disease	0.000146	0.000431	CcSEcCtD
Dantrolene—Vomiting—Captopril—coronary artery disease	0.000145	0.000429	CcSEcCtD
Dantrolene—CYP3A4—Metapathway biotransformation—SULT4A1—coronary artery disease	0.000145	0.000794	CbGpPWpGaD
Dantrolene—Rash—Captopril—coronary artery disease	0.000144	0.000425	CcSEcCtD
Dantrolene—Dermatitis—Captopril—coronary artery disease	0.000144	0.000425	CcSEcCtD
Dantrolene—Somnolence—Lisinopril—coronary artery disease	0.000144	0.000425	CcSEcCtD
Dantrolene—Feeling abnormal—Timolol—coronary artery disease	0.000144	0.000424	CcSEcCtD
Dantrolene—Headache—Captopril—coronary artery disease	0.000143	0.000423	CcSEcCtD
Dantrolene—Gastrointestinal pain—Timolol—coronary artery disease	0.000143	0.000421	CcSEcCtD
Dantrolene—Dizziness—Furosemide—coronary artery disease	0.000143	0.000421	CcSEcCtD
Dantrolene—Dyspepsia—Lisinopril—coronary artery disease	0.000143	0.00042	CcSEcCtD
Dantrolene—Diarrhoea—Losartan—coronary artery disease	0.000143	0.00042	CcSEcCtD
Dantrolene—Nausea—Trandolapril—coronary artery disease	0.000142	0.000419	CcSEcCtD
Dantrolene—Urticaria—Ramipril—coronary artery disease	0.000142	0.000418	CcSEcCtD
Dantrolene—Nausea—Enalapril—coronary artery disease	0.000142	0.000418	CcSEcCtD
Dantrolene—Vomiting—Perindopril—coronary artery disease	0.000141	0.000416	CcSEcCtD
Dantrolene—Abdominal pain—Ramipril—coronary artery disease	0.000141	0.000416	CcSEcCtD
Dantrolene—Body temperature increased—Ramipril—coronary artery disease	0.000141	0.000416	CcSEcCtD
Dantrolene—Decreased appetite—Lisinopril—coronary artery disease	0.000141	0.000415	CcSEcCtD
Dantrolene—Rash—Perindopril—coronary artery disease	0.00014	0.000413	CcSEcCtD
Dantrolene—Dermatitis—Perindopril—coronary artery disease	0.00014	0.000413	CcSEcCtD
Dantrolene—Nausea—Telmisartan—coronary artery disease	0.00014	0.000412	CcSEcCtD
Dantrolene—Fatigue—Lisinopril—coronary artery disease	0.00014	0.000412	CcSEcCtD
Dantrolene—Headache—Perindopril—coronary artery disease	0.000139	0.00041	CcSEcCtD
Dantrolene—Urticaria—Timolol—coronary artery disease	0.000139	0.000409	CcSEcCtD
Dantrolene—Pain—Lisinopril—coronary artery disease	0.000139	0.000408	CcSEcCtD
Dantrolene—Constipation—Lisinopril—coronary artery disease	0.000139	0.000408	CcSEcCtD
Dantrolene—Abdominal pain—Timolol—coronary artery disease	0.000138	0.000407	CcSEcCtD
Dantrolene—Body temperature increased—Timolol—coronary artery disease	0.000138	0.000407	CcSEcCtD
Dantrolene—Dizziness—Losartan—coronary artery disease	0.000138	0.000406	CcSEcCtD
Dantrolene—Vomiting—Furosemide—coronary artery disease	0.000137	0.000405	CcSEcCtD
Dantrolene—Rash—Furosemide—coronary artery disease	0.000136	0.000401	CcSEcCtD
Dantrolene—Dermatitis—Furosemide—coronary artery disease	0.000136	0.000401	CcSEcCtD
Dantrolene—Nausea—Captopril—coronary artery disease	0.000136	0.000401	CcSEcCtD
Dantrolene—Headache—Furosemide—coronary artery disease	0.000135	0.000399	CcSEcCtD
Dantrolene—Feeling abnormal—Lisinopril—coronary artery disease	0.000133	0.000394	CcSEcCtD
Dantrolene—Gastrointestinal pain—Lisinopril—coronary artery disease	0.000132	0.000391	CcSEcCtD
Dantrolene—Vomiting—Losartan—coronary artery disease	0.000132	0.000391	CcSEcCtD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C19—coronary artery disease	0.000132	0.000725	CbGpPWpGaD
Dantrolene—Nausea—Perindopril—coronary artery disease	0.000132	0.000389	CcSEcCtD
Dantrolene—Hypersensitivity—Ramipril—coronary artery disease	0.000132	0.000388	CcSEcCtD
Dantrolene—Rash—Losartan—coronary artery disease	0.000131	0.000387	CcSEcCtD
Dantrolene—Dermatitis—Losartan—coronary artery disease	0.000131	0.000387	CcSEcCtD
Dantrolene—Headache—Losartan—coronary artery disease	0.00013	0.000385	CcSEcCtD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP2C19—coronary artery disease	0.00013	0.000716	CbGpPWpGaD
Dantrolene—Urticaria—Lisinopril—coronary artery disease	0.000129	0.000379	CcSEcCtD
Dantrolene—Hypersensitivity—Timolol—coronary artery disease	0.000129	0.000379	CcSEcCtD
Dantrolene—Nausea—Furosemide—coronary artery disease	0.000128	0.000378	CcSEcCtD
Dantrolene—Asthenia—Ramipril—coronary artery disease	0.000128	0.000378	CcSEcCtD
Dantrolene—Body temperature increased—Lisinopril—coronary artery disease	0.000128	0.000378	CcSEcCtD
Dantrolene—Abdominal pain—Lisinopril—coronary artery disease	0.000128	0.000378	CcSEcCtD
Dantrolene—Pruritus—Ramipril—coronary artery disease	0.000126	0.000373	CcSEcCtD
Dantrolene—Asthenia—Timolol—coronary artery disease	0.000125	0.000369	CcSEcCtD
Dantrolene—Nausea—Losartan—coronary artery disease	0.000124	0.000365	CcSEcCtD
Dantrolene—Pruritus—Timolol—coronary artery disease	0.000124	0.000364	CcSEcCtD
Dantrolene—Diarrhoea—Ramipril—coronary artery disease	0.000122	0.00036	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—ALB—coronary artery disease	0.00012	0.000659	CbGpPWpGaD
Dantrolene—Diarrhoea—Timolol—coronary artery disease	0.000119	0.000352	CcSEcCtD
Dantrolene—Hypersensitivity—Lisinopril—coronary artery disease	0.000119	0.000352	CcSEcCtD
Dantrolene—Dizziness—Ramipril—coronary artery disease	0.000118	0.000348	CcSEcCtD
Dantrolene—Asthenia—Lisinopril—coronary artery disease	0.000116	0.000343	CcSEcCtD
Dantrolene—Dizziness—Timolol—coronary artery disease	0.000115	0.00034	CcSEcCtD
Dantrolene—Pruritus—Lisinopril—coronary artery disease	0.000115	0.000338	CcSEcCtD
Dantrolene—Vomiting—Ramipril—coronary artery disease	0.000114	0.000335	CcSEcCtD
Dantrolene—Rash—Ramipril—coronary artery disease	0.000113	0.000332	CcSEcCtD
Dantrolene—Dermatitis—Ramipril—coronary artery disease	0.000113	0.000332	CcSEcCtD
Dantrolene—Headache—Ramipril—coronary artery disease	0.000112	0.00033	CcSEcCtD
Dantrolene—Vomiting—Timolol—coronary artery disease	0.000111	0.000327	CcSEcCtD
Dantrolene—Diarrhoea—Lisinopril—coronary artery disease	0.000111	0.000327	CcSEcCtD
Dantrolene—Rash—Timolol—coronary artery disease	0.00011	0.000325	CcSEcCtD
Dantrolene—Dermatitis—Timolol—coronary artery disease	0.00011	0.000324	CcSEcCtD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—coronary artery disease	0.00011	0.000603	CbGpPWpGaD
Dantrolene—Headache—Timolol—coronary artery disease	0.000109	0.000323	CcSEcCtD
Dantrolene—CYP3A4—Tryptophan metabolism—CAT—coronary artery disease	0.000108	0.000591	CbGpPWpGaD
Dantrolene—Dizziness—Lisinopril—coronary artery disease	0.000107	0.000316	CcSEcCtD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C19—coronary artery disease	0.000107	0.000588	CbGpPWpGaD
Dantrolene—Nausea—Ramipril—coronary artery disease	0.000106	0.000313	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—GSTM2—coronary artery disease	0.000104	0.000574	CbGpPWpGaD
Dantrolene—Nausea—Timolol—coronary artery disease	0.000104	0.000306	CcSEcCtD
Dantrolene—CYP3A4—Metapathway biotransformation—GSTM2—coronary artery disease	0.000103	0.000566	CbGpPWpGaD
Dantrolene—Vomiting—Lisinopril—coronary artery disease	0.000103	0.000304	CcSEcCtD
Dantrolene—Rash—Lisinopril—coronary artery disease	0.000102	0.000301	CcSEcCtD
Dantrolene—Dermatitis—Lisinopril—coronary artery disease	0.000102	0.000301	CcSEcCtD
Dantrolene—Headache—Lisinopril—coronary artery disease	0.000101	0.000299	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—SULT1E1—coronary artery disease	9.9e-05	0.000544	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—SULT1E1—coronary artery disease	9.77e-05	0.000536	CbGpPWpGaD
Dantrolene—Nausea—Lisinopril—coronary artery disease	9.62e-05	0.000284	CcSEcCtD
Dantrolene—CYP3A4—Metapathway biotransformation—AKR1B1—coronary artery disease	9.32e-05	0.000512	CbGpPWpGaD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—coronary artery disease	9.27e-05	0.000509	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—GCLM—coronary artery disease	8.42e-05	0.000462	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP11B2—coronary artery disease	8.15e-05	0.000448	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP11B2—coronary artery disease	8.04e-05	0.000442	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—SULT1A1—coronary artery disease	7.41e-05	0.000407	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—GPX2—coronary artery disease	7.4e-05	0.000406	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—GPX4—coronary artery disease	7.31e-05	0.000402	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—SULT1A1—coronary artery disease	7.31e-05	0.000402	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—GSTA1—coronary artery disease	7.24e-05	0.000398	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—GPX3—coronary artery disease	6e-05	0.00033	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—ALDH2—coronary artery disease	5.84e-05	0.000321	CbGpPWpGaD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—coronary artery disease	5.8e-05	0.000319	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP2C19—coronary artery disease	5.69e-05	0.000312	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP2C19—coronary artery disease	5.61e-05	0.000308	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—GSTT1—coronary artery disease	5.55e-05	0.000305	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—GCLC—coronary artery disease	5.49e-05	0.000301	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—POMC—coronary artery disease	4.7e-05	0.000258	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—GGT1—coronary artery disease	4.28e-05	0.000235	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CA5B—coronary artery disease	3.89e-05	0.000214	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—GSTP1—coronary artery disease	3.85e-05	0.000211	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—GSTP1—coronary artery disease	3.79e-05	0.000208	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—GSTM1—coronary artery disease	3.54e-05	0.000194	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—GSTM1—coronary artery disease	3.49e-05	0.000192	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CKMT1B—coronary artery disease	3.31e-05	0.000182	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	2.7e-05	0.000148	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CKM—coronary artery disease	2.7e-05	0.000148	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPAP2B—coronary artery disease	2.7e-05	0.000148	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PYGM—coronary artery disease	2.51e-05	0.000138	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CKMT2—coronary artery disease	2.51e-05	0.000138	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SULT4A1—coronary artery disease	2.51e-05	0.000138	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	2.51e-05	0.000138	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PDK4—coronary artery disease	2.51e-05	0.000138	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—POMC—coronary artery disease	2.5e-05	0.000137	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—LDHA—coronary artery disease	2.23e-05	0.000123	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GYG1—coronary artery disease	2.23e-05	0.000123	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PFKM—coronary artery disease	2.23e-05	0.000123	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HMGCS2—coronary artery disease	2.23e-05	0.000123	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GK—coronary artery disease	2.23e-05	0.000123	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GATM—coronary artery disease	2.23e-05	0.000123	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AK1—coronary artery disease	2.13e-05	0.000117	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GCH1—coronary artery disease	2.13e-05	0.000117	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PLCD1—coronary artery disease	2.04e-05	0.000112	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—MDH2—coronary artery disease	2.04e-05	0.000112	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—UGCG—coronary artery disease	2.04e-05	0.000112	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPAT—coronary artery disease	2.04e-05	0.000112	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PGM1—coronary artery disease	1.97e-05	0.000108	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CKB—coronary artery disease	1.9e-05	0.000104	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PYGB—coronary artery disease	1.9e-05	0.000104	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PLIN1—coronary artery disease	1.79e-05	9.81e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—DLAT—coronary artery disease	1.79e-05	9.81e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTM2—coronary artery disease	1.79e-05	9.81e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PFKFB3—coronary artery disease	1.79e-05	9.81e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—COX5B—coronary artery disease	1.79e-05	9.81e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SULT1E1—coronary artery disease	1.69e-05	9.3e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HK2—coronary artery disease	1.62e-05	8.87e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AKR1B1—coronary artery disease	1.62e-05	8.87e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SLC27A1—coronary artery disease	1.55e-05	8.51e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—LCAT—coronary artery disease	1.52e-05	8.34e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CPT1B—coronary artery disease	1.52e-05	8.34e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—APOA4—coronary artery disease	1.49e-05	8.19e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PDHA1—coronary artery disease	1.44e-05	7.91e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GCLM—coronary artery disease	1.44e-05	7.91e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—TXNRD1—coronary artery disease	1.39e-05	7.66e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP11B2—coronary artery disease	1.39e-05	7.66e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SLC22A3—coronary artery disease	1.37e-05	7.54e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HADH—coronary artery disease	1.35e-05	7.44e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.35e-05	7.44e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GPX2—coronary artery disease	1.28e-05	7.05e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	1.28e-05	7.05e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—APOA2—coronary artery disease	1.28e-05	7.05e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ABCG5—coronary artery disease	1.27e-05	6.96e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SULT1A1—coronary artery disease	1.27e-05	6.96e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HK1—coronary artery disease	1.27e-05	6.96e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GPX4—coronary artery disease	1.27e-05	6.96e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HADHA—coronary artery disease	1.25e-05	6.88e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTA1—coronary artery disease	1.24e-05	6.8e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—LPA—coronary artery disease	1.22e-05	6.72e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PLCB3—coronary artery disease	1.19e-05	6.51e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—APOA5—coronary artery disease	1.17e-05	6.45e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—P4HB—coronary artery disease	1.15e-05	6.32e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	1.13e-05	6.21e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—VCAN—coronary artery disease	1.07e-05	5.85e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALDOA—coronary artery disease	1.06e-05	5.8e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—DCN—coronary artery disease	1.03e-05	5.63e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALDH2—coronary artery disease	9.98e-06	5.48e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—LIPC—coronary artery disease	9.73e-06	5.34e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HBA1—coronary artery disease	9.73e-06	5.34e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP2C19—coronary artery disease	9.73e-06	5.34e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	9.73e-06	5.34e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—APOC3—coronary artery disease	9.67e-06	5.31e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—LDLR—coronary artery disease	9.61e-06	5.28e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SLC9A1—coronary artery disease	9.49e-06	5.21e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTT1—coronary artery disease	9.49e-06	5.21e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GCLC—coronary artery disease	9.38e-06	5.15e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CETP—coronary artery disease	9.38e-06	5.15e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SDC1—coronary artery disease	9.28e-06	5.1e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PSMB5—coronary artery disease	8.77e-06	4.81e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PSMA6—coronary artery disease	8.77e-06	4.81e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CTGF—coronary artery disease	8.56e-06	4.7e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HMGCR—coronary artery disease	8.49e-06	4.66e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GOT2—coronary artery disease	8.49e-06	4.66e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PLCB1—coronary artery disease	7.8e-06	4.29e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ABCA1—coronary artery disease	7.56e-06	4.15e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GGT1—coronary artery disease	7.33e-06	4.02e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GOT1—coronary artery disease	7.33e-06	4.02e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTP1—coronary artery disease	6.58e-06	3.61e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	6.52e-06	3.58e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HMOX1—coronary artery disease	6.49e-06	3.56e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CAT—coronary artery disease	6.4e-06	3.52e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—APOB—coronary artery disease	6.22e-06	3.41e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTM1—coronary artery disease	6.05e-06	3.32e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—LPL—coronary artery disease	5.94e-06	3.26e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GPX1—coronary artery disease	5.79e-06	3.18e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CD36—coronary artery disease	5.64e-06	3.1e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPP2CA—coronary artery disease	5.57e-06	3.06e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—MTHFR—coronary artery disease	5.34e-06	2.93e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AGT—coronary artery disease	5.08e-06	2.79e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—APOE—coronary artery disease	4.97e-06	2.73e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—APOA1—coronary artery disease	4.92e-06	2.7e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPARG—coronary artery disease	4.33e-06	2.38e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—POMC—coronary artery disease	4.27e-06	2.35e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALB—coronary artery disease	3.9e-06	2.14e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NOS3—coronary artery disease	3.73e-06	2.05e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PTGS2—coronary artery disease	3.41e-06	1.87e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PIK3CA—coronary artery disease	2.1e-06	1.15e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AKT1—coronary artery disease	1.71e-06	9.41e-06	CbGpPWpGaD
